Top

Current Treatment Options in Cardiovascular Medicine

Published in:

20-12-2023 | Implantable Cardioverter Defibrillator

Racial and Ethnic Disparities in Implantable Cardioverter-Defibrillator Utilization: A Contemporary Review

Authors: Tarryn Tertulien, MD, MSc, Kelvin Bush, MD, Larry R. Jackson II, MD, MHS, Utibe R. Essien, MD, MPH, Lauren Eberly, MD, MPH

Published in: Current Treatment Options in Cardiovascular Medicine | Issue 12/2023

Abstract

Purpose of review

Sudden cardiac arrest is associated with high morbidity and mortality. Despite having a disproportionate burden of sudden cardiac death (SCD), rates of primary and secondary prevention of SCD with implantable cardioverter-defibrillator (ICD) therapy are lower among eligible racially minoritized patients. This review highlights the racial and ethnic disparities in ICD utilization, associated barriers to ICD care, and proposed interventions to improve equitable ICD uptake.

Recent findings

Racially minoritized populations are disproportionately eligible for ICD therapy but are less likely to see cardiac specialists, be counseled on ICD therapy, and ultimately undergo ICD implantation, fueling disparate outcomes. Racial disparities in ICD utilization are multifactorial, with contributions at the patient, provider, health system, and structural/societal level.

Summary

Racial and ethnic disparities have been demonstrated in preventing SCD with ICD use. Proposed strategies to mitigate these disparities must prioritize care delivery and access to care for racially minoritized patients, increase the diversification of clinical and implementation trial participants and the healthcare workforce, and center reparative justice frameworks to rectify a long history of racial injustice.

Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Heart Rhythm. 2018;15(10):e73–189. https://doi.org/10.1016/j.hrthm.2017.10.036.CrossRefPubMed

Mensah GA, Mokdad AH, Ford ES, Greenlund KJ, Croft JB. State of disparities in cardiovascular health in the United States. Circulation. 2005;111(10):1233–41.CrossRefPubMed

Javed Z, Haisum Maqsood M, Yahya T, Amin Z, Acquah I, Valero-Elizondo J, et al. Race, racism, and cardiovascular health: applying a social determinants of health framework to racial/ethnic disparities in cardiovascular disease. Circulation. 2022;15(1). https://doi.org/10.1161/circoutcomes.121.007917.

Brown RM, Tamazi S, Weinberg CR, Dwivedi A, Mieres JH. Racial disparities in cardiovascular risk and cardiovascular care in women. Curr Cardiol Rep. 2022;24(9):1197–208. https://doi.org/10.1007/s11886-022-01738-w.CrossRefPubMed

Albert MA, Carnethon MR, Watson KE. Disparities in cardiovascular medicine. Circulation. 2021;143(24):2319–20. https://doi.org/10.1161/CIRCULATIONAHA.121.055565.CrossRefPubMed

Institute of Medicine Committee on UE, Racial Ethnic Disparities in Health Care. In: Smedley BD, Stith AY, Nelson AR, editors. Unequal treatment: confronting racial and ethnic disparities in health care. Washington (DC): National Academies Press (US) Copyright 2002 by the National Academy of Sciences. All rights reserved; 2003.

Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implantable cardioverter–defibrillator for congestive heart failure. N Engl J Med. 2005;352(3):225–37. https://doi.org/10.1056/nejmoa043399.CrossRefPubMed

Buxton AE, Lee KL, Fisher JD, Josephson MD, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter unsustained tachycardia trial investigators. New Eng J Med. 1999;341:1882–90. https://doi.org/10.1056/NEJM199912163412503.

Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346(12):877–83. https://doi.org/10.1056/nejmoa013474.CrossRefPubMed

10.

Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. New Eng J Med. 1996;335(26):1933–40. https://doi.org/10.1056/NEJM199612263352601.

11.

Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R, et al. Prophylactic use of an implantable cardioverter–defibrillator after acute myocardial infarction. N Engl J Med. 2004;351(24):2481–8. https://doi.org/10.1056/nejmoa041489.CrossRefPubMed

12.

Hernandez AF, Fonarow GC, Liang L, Al-Khatib SM, Curtis LH, Labresh KA, et al. Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. JAMA. 2007;298(13). https://doi.org/10.1001/jama.298.13.1525.

13.

Stanley A, DeLia D, Cantor JC. Racial disparity and technology diffusion: the case of cardioverter defibrillator implants, 1996–2001. J Natl Med Assoc. 2007;99(3):201.PubMedPubMedCentral

14.

Thomas KL, Al-Khatib SM, Kelsey RC 2nd, Bush H, Brosius L, Velazquez EJ, et al. Racial disparity in the utilization of implantable-cardioverter defibrillators among patients with prior myocardial infarction and an ejection fraction of <or=35%. Am J Cardiol. 2007;100(6):924–9. https://doi.org/10.1016/j.amjcard.2007.04.024.CrossRefPubMed

15.

Steiner HA, Miller JM. Disparity in utilization of implantable cardioverter-defibrillators in treatment of heart failure based on sex and race. Womens Health. 2008;4(1):23–5. https://doi.org/10.2217/17455057.4.1.23.CrossRef

16.

Jones CP. Levels of racism: a theoretic framework and a gardener’s tale. Am J Public Health. 2000;90(8):1212–5. https://doi.org/10.2105/ajph.90.8.1212.CrossRefPubMed

17.

Tertulien T, Broughton ST, Swabe G, Essien UR, Magnani JW. Association of race and ethnicity on the management of acute non−ST‐segment elevation myocardial infarction. J Am Heart Assoc. 2022;11(12). https://doi.org/10.1161/jaha.121.025758.

18.

Al-Khatib SM, Hellkamp AS, Hernandez AF, Fonarow GC, Thomas KL, Al-Khalidi HR, et al. Trends in use of implantable cardioverter-defibrillator therapy among patients hospitalized for heart failure: have the previously observed sex and racial disparities changed over time? Circulation. 2012;125(9):1094–101. https://doi.org/10.1161/CIRCULATIONAHA.111.066605.CrossRefPubMedPubMedCentral

19.

Patel N, Deshmukh A, Thakkar B, Coffey JO, Agnihotri K, Patel A, et al. Gender, race, and health insurance status in patients undergoing catheter ablation for atrial fibrillation. Am J Cardiol. 2016;117(7):1117–26. https://doi.org/10.1016/j.amjcard.2016.01.040.CrossRef

20.

Becker LB, Han BH, Meyer PM, Wright FA, Rhodes KV, Smith DW, et al. Racial differences in the incidence of cardiac arrest and subsequent survival. The CPR Chicago Project. New Eng J Med. 1993;329(9):600–6. https://doi.org/10.1056/nejm199308263290902.

21.

Reinier K, Rusinaru C, Chugh SS. Race, ethnicity, and the risk of sudden death. Trends Cardiovasc Med. 2019;29(2):120–6. https://doi.org/10.1016/j.tcm.2018.07.001.CrossRefPubMed

22.

Zhao D, Post WS, Blasco-Colmenares E, Cheng A, Zhang Y, Deo R, et al. Racial differences in sudden cardiac death. Circulation. 2019;139(14):1688–97. https://doi.org/10.1161/circulationaha.118.036553.CrossRefPubMedPubMedCentral

23.

•• Hess PL, Hernandez AF, Bhatt DL, Hellkamp AS, Yancy CW, Schwamm LH, et al. Sex and race/ethnicity differences in implantable cardioverter-defibrillator counseling and use among patients hospitalized with heart failure: findings from the get with the guidelines-heart failure program. Circulation. 2016;134(7):517–26. https://doi.org/10.1161/CIRCULATIONAHA.115.021048. Large cohort of 13 034 patients admitted with heart failure and ejection fraction of 30% or less who were eligible for ICD, which demonstrated rates of ICD utilization were significantly lower among Black than White patients. Race persisted as a significant predictor of lower ICD utilization, even after adjusting for patient factors and hospital characteristics in hierarchical models.

24.

El-Chami MF, Hanna IR, Bush H, Langberg JJ. Impact of race and gender on cardiac device implantations. Heart Rhythm. 2007;4(11):1420–6. https://doi.org/10.1016/j.hrthm.2007.07.024.CrossRefPubMed

25.

Gauri AJ, Davis A, Hong T, Burke MC, Knight BP. Disparities in the use of primary prevention and defibrillator therapy among Blacks and women. Am J Med. 2006;119(2):167.e17–.e21. https://doi.org/10.1016/j.amjmed.2005.08.021.

26.

Khazanchi R, Evans CT, Marcelin JR. Racism, not race, drives inequity across the COVID-19 continuum. JAMA Network Open. 2020;3(9):e2019933-e. https://doi.org/10.1001/jamanetworkopen.2020.19933.

27.

Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18). https://doi.org/10.1161/cir.0000000000001063.

28.

Kadish A, Dyer A, Daubert JP, Quigg R, Estes NAM, Anderson KP, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004;350(21):2151–8. https://doi.org/10.1056/nejmoa033088.CrossRef

29.

Mitchell JE, Hellkamp AS, Mark DB, Anderson J, Poole JE, Lee KL, et al. Outcome in African Americans and other minorities in the sudden cardiac death in heart failure trial (SCD-HeFT). Am Heart J. 2008;155(3):501–6. https://doi.org/10.1016/j.ahj.2007.10.022.CrossRefPubMed

30.

Tertulien T, Magnani JW, Essien UR. Racial and ethnic representation in atrial fibrillation trials. J Am Coll Cardiol. 2021;78(19):e163–4. https://doi.org/10.1016/j.jacc.2021.08.054.CrossRefPubMed

31.

Bureau USC: quick facts United States: population estimates. 2022. https://www.census.gov/quickfacts/fact/table/US/PST045222#PST045222. Accessed 18 Apr 2023.

32.

Pokorney SD, Hellkamp AS, Yancy CW, Curtis LH, Hammill SC, Peterson ED, et al. Primary prevention implantable cardioverter-defibrillators in older racial and ethnic minority patients. Circ Arrhythm Electrophysiol. 2015;8(1):145–51. https://doi.org/10.1161/CIRCEP.114.001878.CrossRef

33.

Thalappillil A, Johnson A, Althouse A, Thoma F, Lee J, Estes NAM, et al. Impact of an automated best practice alert on sex and race disparities in implantable cardioverter‐defibrillator therapy. J Am Heart Assoc. 2022;11(7). https://doi.org/10.1161/jaha.121.023669.

34.

Thomas KL, Sullivan LT 2nd, Al-Khatib SM, LaPointe NA, Sears S, Kosinski AS, et al. Videos to reduce racial disparities in ICD therapy via innovative designs (VIVID) trial: rational, design and methodology. Am Heart J. 2020;220:59–67. https://doi.org/10.1016/j.ahj.2019.10.011.CrossRefPubMed

35.

Patel NJ, Edla S, Deshmukh A, Nalluri N, Patel N, Agnihotri K, et al. Gender, racial, and health insurance differences in the trend of implantable cardioverter-defibrillator (ICD) utilization: a United States experience over the last decade. Clin Cardiol. 2016;39(2):63–71. https://doi.org/10.1002/clc.22496.CrossRefPubMedPubMedCentral

36.

Eapen ZJ, Al-Khatib S, Lopes RD, Wang Y, Bao H, Curtis J, et al. Are racial/ethnic gaps in the use of cardiac resynchronization therapy narrowing?: an analysis of 107,096 patients from the National Cardiovascular Data Registry’s ICD Registry. J Am Coll Cardiol. 2012;60(16):1577–8. https://doi.org/10.1016/j.jacc.2012.06.024.

37.

Patlolla SH, Schaff HV, Nishimura RA, Geske JB, Dunlay SM, Ommen SR. Sex and race disparities in hypertrophic cardiomyopathy: unequal implantable cardioverter-defibrillator use during hospitalization. Mayo Clin Proc. 2022;97(3):507–18. https://doi.org/10.1016/j.mayocp.2021.07.022.CrossRefPubMed

38.

Eberly LA, Day SM, Ashley EA, Jacoby DL, Jefferies JL, Colan SD, et al. Association of race with disease expression and clinical outcomes among patients with hypertrophic cardiomyopathy. JAMA Cardiol. 2020;5(1):83. https://doi.org/10.1001/jamacardio.2019.4638.

39.

Voigt A, Ezzeddine R, Barrington W, Obiaha-Ngwu O, Ganz LI, London B, et al. Utilization of implantable cardioverter-defibrillators in survivors of cardiac arrest in the United States from 1996 to 2001. J Am Coll Cardiol. 2004;44(4):855–8. https://doi.org/10.1016/j.jacc.2004.05.053.CrossRefPubMed

40.

Groeneveld PW, Heidenreich PA, Garber AM. Racial disparity in cardiac procedures and mortality among long-term survivors of cardiac arrest. Circulation. 2003;108(3):286–91. https://doi.org/10.1161/01.CIR.0000079164.95019.5A.CrossRefPubMed

41.

Alexander M, Baker L, Clark C, McDonald KM, Rowell R, Saynina O, et al. Management of ventricular arrhythmias in diverse populations in California. Am Heart J. 2002;144(3):431–9. https://doi.org/10.1067/mhj.2002.125500.CrossRefPubMed

42.

American Heart Association's get with the guidelines - heart failure quality improvement program. 2023. https://www.heart.org/en/professional/quality-improvement/get-with-the-guidelines/get-with-the-guidelines-heart-failure/get-with-the-guidelines-hf-registry-tool. Accessed 9 Apr 2023.

43.

Ntusi NAB, Sliwa K. Associations of race and ethnicity with presentation and outcomes of hypertrophic cardiomyopathy: JACC focus seminar 6/9. J Am Coll Cardiol. 2021;78(25):2573–9. https://doi.org/10.1016/j.jacc.2021.10.020.CrossRefPubMed

44.

Groeneweg JA, Bhonsale A, James CA, te Riele AS, Dooijes D, Tichnell C, et al. Clinical presentation, long-term follow-up, and outcomes of 1001 arrhythmogenic right ventricular dysplasia/cardiomyopathy patients and family members. Circ Cardiovasc Genet. 2015;8(3):437–46. https://doi.org/10.1161/circgenetics.114.001003.CrossRef

45.

Dereci A, Yap SC, Schinkel AFL. Meta-analysis of clinical outcome after implantable cardioverter-defibrillator implantation in patients with Brugada Syndrome. JACC Clin Electrophysiol. 2019;5(2):141–8. https://doi.org/10.1016/j.jacep.2018.09.005.CrossRefPubMed

46.

Galea S, Blaney S, Nandi A, Silverman R, Vlahov D, Foltin G, et al. Explaining racial disparities in incidence of and survival from out-of-hospital cardiac arrest. Am J Epidemiol. 2007;166(5):534–43. https://doi.org/10.1093/aje/kwm102.CrossRef

47.

Cowie MR, Fahrenbruch CE, Cobb LA, Hallstrom AP. Out-of-hospital cardiac arrest: racial differences in outcome in Seattle. Am J Public Health. 1993;83(7):955–9. https://doi.org/10.2105/ajph.83.7.955.CrossRefPubMedPubMedCentral

48.

A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. New Eng J Med. 1997;337(22):1576–84. https://doi.org/10.1056/nejm199711273372202.

49.

Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS, et al. Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation. 2000;101(11):1297–302. https://doi.org/10.1161/01.cir.101.11.1297.CrossRefPubMed

50.

Kuck KH, Cappato R, Siebels J, Rüppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation. 2000;102(7):748–54. https://doi.org/10.1161/01.cir.102.7.748.

51.

•• Groeneveld PW, Heidenreich PA, Garber AM. Trends in implantable cardioverter-defibrillator racial disparity: the importance of geography. J Am Coll Cardiol. 2005;45(1):72–8. https://doi.org/10.1016/j.jacc.2004.07.061. Black elderly patients hospitalized with cardiac arrest or ventricular arrhythmia between 1990 and 2000). Demonstrated that Black patients were less likely to receive ICD for secondary prevention as compared to White patients (OR 0.52 (95% CI 0.42 to 0.64) at the start of the study period. [51] By the end of the study period, the racial gap had improved but was not eliminated; OR for Black patients had risen to 0.69 (95% CI 0.61 to 0.78).

52.

Gordon HS, Paterniti DA, Wray NP. Race and patient refusal of invasive cardiac procedures. J Gen Intern Med. 2004;19(9):962–6. https://doi.org/10.1111/j.1525-1497.2004.30131.x.CrossRefPubMed

53.

Barnhart JM, Cohen O, Wright N, Wylie-Rosett J. Can non-medical factors contribute to disparities in coronary heart disease treatments? J Health Care Poor Underserved. 2006;17(3):559–74. https://doi.org/10.1353/hpu.2006.0097.CrossRefPubMed

54.

Cascino TM, Colvin MM, Lanfear DE, Richards B, Khalatbari S, Mann DL, et al. Racial inequities in access to ventricular assist device and transplant persist after consideration for preferences for care: a report from the REVIVAL study. Circulation: Heart Failure. 2023;16(1). https://doi.org/10.1161/circheartfailure.122.009745.

55.

Groeneveld PW, Sonnad SS, Lee AK, Asch DA, Shea JE. Racial differences in attitudes toward innovative medical technology. J Gen Intern Med. 2006;21(6):559–63. https://doi.org/10.1111/j.1525-1497.2006.00453.x.CrossRefPubMedPubMedCentral

56.

Wiltshire J, Cronin K, Sarto GE, Brown R. Self-advocacy during the medical encounter: use of health information and racial/ethnic differences. Medical Care. 2006:100–9.

57.

Eneanya ND, Winter M, Cabral H, Waite K, Henault L, Bickmore T, et al. Health literacy and education as mediators of racial disparities in patient activation within an elderly patient cohort. J Health Care Poor Underserved. 2016;27(3):1427–40. https://doi.org/10.1353/hpu.2016.0133.CrossRefPubMedPubMedCentral

58.

• Thomas KL, Al-Khatib SM, Kosinski AS, Sears SF Jr, Allen LaPointe NM, Jackson LR 2nd, et al. Facilitating shared decision making among black patients at risk for sudden cardiac arrest : a randomized clinical trial. Ann Intern Med. 2023;176(5):615–23. https://doi.org/10.7326/m22-2934. Randomized control trial of Black adults with HF eligible for primary prevention ICD to assess the effectiveness of a video decision support tool. A video-based decision support tool increased patient knowledge but did not increase assent to ICD implantation.

59.

Brewer LC, Pasha M, Seele P, Penheiter S, White R, Willis F, et al. Overcoming historical barriers: enhancing positive perceptions of medical research among African Americans through a conference-based workshop. J General Intern Med. 2021;1–8.

60.

Bradfield J, Warner A, Bersohn MM. Low referral rate for prophylactic implantation of cardioverter-defibrillators in a tertiary care medical center. Pacing Clin Electrophysiol. 2009;32(Suppl 1):S194–7. https://doi.org/10.1111/j.1540-8159.2008.02281.x.CrossRef

61.

Pillarisetti J, Emert M, Biria M, Chotia R, Guda R, Bommana S, et al. Under-utilization of implantable cardioverter defibrillators in patients with heart failure - the current state of sudden cardiac death prophylaxis. Indian Pacing Electrophysiol J. 2015;15(1):20–9. https://doi.org/10.1016/S0972-6292(16)30838-5.CrossRef

62.

Johnson RL, Roter D, Powe NR, Cooper LA. Patient race/ethnicity and quality of patient–physician communication during medical visits. Am J Public Health. 2004;94(12):2084–90. https://doi.org/10.2105/ajph.94.12.2084.CrossRefPubMedCentral

63.

Serber ER, Finch NJ, Leman RB, Sturdivant LJ, Barnes T, Clarke E, et al. Disparities in preferences for receiving support and education among patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol. 2009;32(3):383–90. https://doi.org/10.1111/j.1540-8159.2008.02248.x.CrossRefPubMed

64.

Cook NL, Ayanian JZ, Orav EJ, Hicks LS. Differences in specialist consultations for cardiovascular disease by race, ethnicity, gender, insurance status, and site of primary care. Circulation. 2009;119(18):2463–70. https://doi.org/10.1161/circulationaha.108.825133.CrossRefPubMed

65.

Eberly LA, Garg L, Yang L, et al. Racial/ethnic and socioeconomic disparities in management of incident paroxysmal atrial fibrillation. JAMA Netw Open. 2021;4(2):e210247. https://doi.org/10.1001/jamanetworkopen.2021.0247.CrossRefPubMed

66.

• Lee J, Szeto L, Pasupula DK, Hussain A, Waheed A, Adhikari S, et al. Cluster randomized trial examining the impact of automated best practice alert on rates of implantable defibrillator therapy. Circulation. 2019;12(6). https://doi.org/10.1161/circoutcomes.118.005024. Cluster randomized trial evaluating the impact of a best practice alert through the electronic health record recommending to providers consideration of ICD implantation when the left ventricular ejection fraction is ≤35%. Resulted in improved the rates of electrophysiology referrals and ICD therapy in patients with severe left ventricular dysfunction.

67.

Wispelwey BP, Marsh RH, Wilson M, Mazimba S, Heysell SK, Aisiku IP, et al. Leveraging clinical decision support for racial equity: a sociotechnical innovation. Catalyst Non-issue Content. 2022;3(4). https://doi.org/10.1056/CAT.22.0076.

68.

Johnson AE, Birru Talabi M, Bonifacino E, Culyba AJ, Jonassaint NL, Nance MA, et al. Considerations for racial diversity in the cardiology workforce in the United States of America. J Am Coll Cardiol. 2021;77(15):1934–7. https://doi.org/10.1016/j.jacc.2021.02.043.CrossRef

69.

Capers Qt, Johnson A, Berlacher K, Douglas PS. The urgent and ongoing need for diversity, inclusion, and equity in the cardiology workforce in the United States. J Am Heart Assoc. 2021;10(6):e018893. https://doi.org/10.1161/JAHA.120.018893.

70.

Groeneveld PW, Laufer SB, Garber AM. Technology diffusion, hospital variation, and racial disparities among elderly Medicare beneficiaries: 1989–2000. Med Care. 2005;43(4):320–9. https://doi.org/10.1097/01.mlr.0000156849.15166.ec.CrossRefPubMed

71.

• Diamond J, Ayodele I, Fonarow GC, Joynt-Maddox KE, Yeh RW, Hammond G, et al. Quality of care and clinical outcomes for patients with heart failure at hospitals caring for a high proportion of black adults: get with the guidelines-heart failure registry. JAMA Cardiol. 2023. https://doi.org/10.1001/jamacardio.2023.0695. A recent study evaluating Get-With the Guideline metrics between Medicare patients cared for at hospitals with high proportions of Black patients compared with other hospitals found that quality of care for ICD metrics was similar between hospitals with high proportions of Black patients compared with other hospitals. The findings suggest inequities are not likely driven by Black patients seeking care at poorer quality hospitals.

72.

Howard BV, Lee ET, Cowan LD, Devereux RB, Galloway JM, Go OT, et al. Rising tide of cardiovascular disease in American Indians. The Strong Heart Study Circulation. 1999;99(18):2389–95. https://doi.org/10.1161/01.cir.99.18.2389.CrossRefPubMed

73.

Kelsey MD, Patrick-Lake B, Abdulai R, Broedl UC, Brown A, Cohn E, et al. Inclusion and diversity in clinical trials: actionable steps to drive lasting change. Contemp Clin Trials. 2022;116:106740. https://doi.org/10.1016/j.cct.2022.106740.CrossRefPubMed

74.

Eberly LA, Khatana SAM, Nathan AS, Snider C, Julien HM, Deleener ME, et al. Telemedicine outpatient cardiovascular care during the COVID-19 pandemic. Circulation. 2020;142(5):510–2. https://doi.org/10.1161/circulationaha.120.048185.CrossRefPubMedPubMedCentral

75.

Eberly LA, Kallan MJ, Julien HM, Haynes N, Khatana SAM, Nathan AS, et al. Patient characteristics associated with telemedicine access for primary and specialty ambulatory care during the COVID-19 pandemic. JAMA Netw Open. 2020;3(12):e2031640. https://doi.org/10.1001/jamanetworkopen.2020.31640.CrossRefPubMedPubMedCentral

76.

Anastos-Wallen RE, Mitra N, Coburn BW, Shultz K, Rhodes C, Snider C, et al. Primary care appointment completion rates and telemedicine utilization among black and non-black patients from 2019 to 2020. Telemed J E Health. 2022;28(12):1786–95. https://doi.org/10.1089/tmj.2022.0104.CrossRefPubMedPubMedCentral

77.

Ford CL, Airhihenbuwa CO. Critical race theory, race equity, and public health: toward antiracism praxis. Am J Public Health. 2010;100 Suppl 1(Suppl 1):S30–5. https://doi.org/10.2105/ajph.2009.171058.

78.

Wispelwey B, Morse, M. An antiracist agenda for Medicine Boston Review Online 2021. https://www.bostonreview.net/articles/michelle-morsebram-wispelwey-what-we-owe-patients-case-medical-reparations/. Accessed 5 May 2023.

Title: Racial and Ethnic Disparities in Implantable Cardioverter-Defibrillator Utilization: A Contemporary Review
Authors: Tarryn Tertulien, MD, MSc
Kelvin Bush, MD
Larry R. Jackson II, MD, MHS
Utibe R. Essien, MD, MPH
Lauren Eberly, MD, MPH
Publication date: 20-12-2023
Publisher: Springer US
Keywords: Implantable Cardioverter Defibrillator
Implantable Cardioverter Defibrillator
ICD Implantation
ICD Implantation
ICD Implantation
Sudden Cardiac Death
Heart Failure
Cardiomyopathy
Published in: Current Treatment Options in Cardiovascular Medicine / Issue 12/2023
Print ISSN: 1092-8464
Electronic ISSN: 1534-3189
DOI: https://doi.org/10.1007/s11936-023-01025-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Racial and Ethnic Disparities in Implantable Cardioverter-Defibrillator Utilization: A Contemporary Review

Abstract

Purpose of review

Recent findings

Summary

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose of review

Recent findings

Summary

Please log in to get access to this content

Other articles of this Issue 12/2023

Digital Tools for Decision-Making in Coronary Artery Disease

Aortic Regurgitation: Diagnosis and Evaluation

Current Percutaneous Approaches to Treat Mitral Valve Regurgitation

Immunotherapy-Associated Atherosclerosis: A Comprehensive Review of Recent Findings and Implications for Future Research

Autonomic Modulation Options in Cardiovascular Disease Treatment: Current and Emerging

Who Should Interpret Screening Preparticipation ECGs in Young Athletes?